Literature DB >> 12884967

Hippocampal infection with HSV-1-derived vectors expressing an NMDAR1 antisense modifies behavior.

M F Adrover1, V Guyot-Revol, V T Cheli, C Blanco, R Vidal, L Alché, E Kornisiuk, A L Epstein, D Jerusalinsky.   

Abstract

Herpes simplex virus-derived amplicon vectors simultaneously expressing the open reading frame encoding NR1 subunit of the NMDA receptor, either in sense or antisense orientation, as well as the open reading frame encoding the green fluorescent protein (GFP), as distinct transcription units, were constructed. Vector expression in cells was demonstrated by GFP-fluorescence, immunofluorescence, Western blots and RT-PCR. The vectors were inoculated into the dorsal hippocampus of adult male rats, which were then trained for habituation to an open field and for inhibitory avoidance to a foot-shock. Those animals injected with vectors expressing NR1 protein showed habituation to a new environment, and achieved the criteria for a step-down inhibitory avoidance to a foot-shock. In contrast, animals injected with vectors carrying the NR1 open reading frame in antisense position, showed neither habituation nor appropriate performance in the inhibitory avoidance task. There was no evidence for motor impairment or motivational disturbance, since all the animals exhibit similar behavior and performance in the training sessions. Hence, the impaired performance might be due to either amnesia or disability to record events. Transgene expression in brain, as revealed by GFP fluorescence, was mainly observed in pyramidal cells of CA1, but also in CA3. Therefore, our results strongly support the participation of hippocampal NR1 subunit in habituation to a new environment, but also in recording events for the inhibitory avoidance task. Hence, amplicon vectors appear to be useful tools to modify endogenous gene expression at a defined period, in restricted brain regions, and should allow investigating in vivo functions of genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884967     DOI: 10.1034/j.1601-183x.2003.00015.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  6 in total

1.  Identification of transmitter systems and learning tag molecules involved in behavioral tagging during memory formation.

Authors:  Diego Moncada; Fabricio Ballarini; María Cecilia Martinez; Julietta U Frey; Haydee Viola
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

Review 2.  Methods for gene transfer to the central nervous system.

Authors:  Boris Kantor; Rachel M Bailey; Keon Wimberly; Sahana N Kalburgi; Steven J Gray
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

3.  Knockdown and overexpression of NR1 modulates NMDA receptor function.

Authors:  Maggie L Kalev-Zylinska; Wymond Symes; Deborah Young; Matthew J During
Journal:  Mol Cell Neurosci       Date:  2009-04-24       Impact factor: 4.314

4.  GluN1 and GluN2A NMDA Receptor Subunits Increase in the Hippocampus during Memory Consolidation in the Rat.

Authors:  Magali C Cercato; Cecilia A Vázquez; Edgar Kornisiuk; Alejandra I Aguirre; Natalia Colettis; Marina Snitcofsky; Diana A Jerusalinsky; María V Baez
Journal:  Front Behav Neurosci       Date:  2017-01-13       Impact factor: 3.558

5.  Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells.

Authors:  Marie Soukupová; Silvia Zucchini; Pascal Trempat; Selene Ingusci; Coline Perrier-Biollay; Mario Barbieri; Stefano Cattaneo; Barbara Bettegazzi; Simonetta Falzoni; Hervé Berthommé; Michele Simonato
Journal:  Mol Ther Methods Clin Dev       Date:  2021-03-29       Impact factor: 6.698

6.  Construction and characterization of a new TRAIL soluble form, active at picomolar concentrations.

Authors:  Matias Eliseo Melendez; Renato José Silva-Oliveira; Anna Luiza Silva Almeida Vicente; Lidia Maria Rebolho Batista Arantes; Ana Carolina de Carvalho; Alberto Luis Epstein; Rui Manuel Reis; André Lopes Carvalho
Journal:  Oncotarget       Date:  2018-06-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.